Understanding Your Weight Management Medication Options
Ozempic vs Wegovy vs Mounjaro: Licensed Indications and Legal UK Supply
The fundamental difference when comparing Ozempic vs Wegovy vs Mounjaro lies in their MHRA licensing. Ozempic contains semaglutide but is licensed exclusively for type 2 diabetes management, making its prescription for weight loss illegal off-label promotion in the UK. Wegovy, also containing semaglutide, received specific MHRA approval for chronic weight management in adults with BMI ≥30 or BMI ≥27 with weight-related comorbidities. Mounjaro (tirzepatide) represents a newer dual-action approach, targeting both GIP and GLP-1 receptors for weight management.
EverydayMeds, as a GPhC-registered online pharmacy (#9012878), can legally supply both Wegovy and Mounjaro following proper clinical assessment. When evaluating Ozempic vs Wegovy vs Mounjaro for weight management, only Wegovy and Mounjaro should be considered, as both are prescription-only medicines specifically designed for this indication alongside a reduced-calorie diet and increased physical activity. Our prescribers assess each patient individually to determine the most appropriate treatment option.
Wegovy and Mounjaro Pricing: UK Online Purchase Options
Understanding the cost implications when comparing Ozempic vs Wegovy vs Mounjaro helps inform your decision. Wegovy pricing at EverydayMeds starts from £79.99 for the 0.25mg starter dose (weeks 1-4) with new customer code FIRST40 applied at checkout. Dose escalation follows a structured pathway: 0.5mg at £94.99, 1mg at £99.99, 1.7mg at £139.99, and maintenance 2.4mg at £209.99. Returning customers benefit from code DOSE25 for continued savings throughout their treatment journey.
Our bundle options provide convenient multi-dose packages: the Intro Duo (0.25mg & 0.5mg) costs £169.99, whilst the Progress Trio (0.5mg, 1mg & 1.7mg) offers three months of step-up dosing for £369.99. The Ultimate Stability Trio provides three months of maintenance 2.4mg supply for £649.99, ensuring treatment continuity. All prices include prescriber consultation, clinical review, and next-day delivery, making the Ozempic vs Wegovy vs Mounjaro comparison straightforward from a value perspective.
Clinical Evidence: STEP Trials for Ozempic vs Wegovy vs Mounjaro Comparison
When examining Ozempic vs Wegovy vs Mounjaro through clinical evidence, the STEP trial programme demonstrates Wegovy's efficacy in weight management. In clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). STEP 5 data showed sustained 15.2% weight reduction at two years, whilst the SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events.
Mounjaro's clinical evidence comes from the SURMOUNT trials, showing the dual GIP+GLP-1 mechanism's potential benefits. However, direct head-to-head comparisons between these treatments aren't available due to different trial designs and populations. Both medications require ongoing commitment, as STEP 1 extension data shows patients regained approximately two-thirds of weight lost within one year of stopping treatment, emphasising that weight management represents a long-term commitment.
How Wegovy Works: GLP-1 Mechanism in Ozempic vs Wegovy vs Mounjaro Context
Understanding how Wegovy functions helps clarify the Ozempic vs Wegovy vs Mounjaro comparison mechanistically. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to reduce appetite and promote satiety after smaller meals. The medication works on brain appetite centres, potentially reducing food cravings and helping patients feel satisfied with reduced portion sizes. Unlike Mounjaro's dual GIP+GLP-1 action, Wegovy focuses specifically on GLP-1 pathways for appetite regulation. This once-weekly injectable prescription-only medicine must be used alongside dietary modifications and increased physical activity for optimal results. The FlexTouch pen delivery system ensures precise dosing throughout the mandatory escalation schedule.
Ordering Process: Buy Wegovy Online Through EverydayMeds
Purchasing Wegovy online involves a streamlined three-step process designed for safety and convenience. The initial three-minute clinical assessment captures essential medical history, current medications, and weight management goals to ensure Wegovy suitability. Our GPhC-registered prescribers (#9012878) review each assessment within standard three working days, or 24 hours with express service, ensuring thorough evaluation before approval. Once prescribed, next-day cold-chain delivery maintains medication integrity through temperature-controlled packaging across the UK. The process includes comprehensive patient information, injection training materials, and ongoing support throughout your weight management journey. All consultations include prescriber follow-up recommendations and monitoring guidelines for safe, effective treatment.
Storage and Practical Considerations: Wegovy vs Mounjaro Comparison
Practical factors influence the Ozempic vs Wegovy vs Mounjaro decision, particularly storage requirements and convenience. Wegovy requires refrigeration at 2-8°C before first use but offers superior travel flexibility with six weeks room temperature stability below 30°C once removed from refrigeration. This compares favourably to Mounjaro's 21-day room temperature limit, making Wegovy more suitable for frequent travellers. The FlexTouch pen system delivers precise doses through a simple injection process, with dose escalation mandatory over 16 weeks to reach the 2.4mg maintenance dose. Each pen contains four doses, with injection sites rotated between thigh, abdomen, or upper arm. The structured dosing schedule cannot be accelerated, ensuring optimal tolerability as your body adjusts to this prescription-only medicine.
Licensed Weight Management: Why Wegovy and Mounjaro Excel Over Ozempic
The regulatory landscape clearly distinguishes between these options when comparing Ozempic vs Wegovy vs Mounjaro for weight management purposes. Wegovy received specific MHRA approval following comprehensive clinical trials in obesity populations, with NICE recommendation TA875 supporting its use with specialist weight management programmes. This targeted licensing ensures appropriate patient selection, monitoring protocols, and safety frameworks specifically designed for weight management rather than diabetes care.
Mounjaro's weight management licensing brings innovative dual-hormone targeting to UK patients, whilst Ozempic remains restricted to diabetes indications only. Both Wegovy and Mounjaro are available through EverydayMeds following proper clinical assessment, with our prescribers determining individual suitability based on BMI, comorbidities, and treatment history. This legal framework protects patients whilst ensuring access to evidence-based weight management medications through regulated pharmacy channels.
Start Your Weight Management Journey: Apply Discount Codes Today
Beginning treatment requires simple steps to access genuine medication safely and legally. New customers receive £40 off their first order with code FIRST40 applied at checkout, making the 0.25mg starter dose £79.99 rather than standard pricing. Returning customers benefit from ongoing savings with code DOSE25 for continued treatment affordability. The comprehensive service includes prescriber consultation, clinical review, medication supply, and delivery—representing exceptional value compared to traditional private clinic consultations. EverydayMeds combines convenience with clinical excellence, ensuring your weight management journey begins with proper medical oversight and genuine pharmaceutical-grade medication. Ready to start? Visit https://everydaymeds.co.uk/collections/wegovy to begin your assessment today.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
